Sector portfolio · Private equity · United States

Vivo Capital's Biotech portfolio

Vivo Capital has backed 67 Biotech startups in rounds we track, $11B between them, shown by the stage each has reached. The best-funded is Celcuity.

67startups backed
5stages
$11Braised between them
Stage not reportedbiggest stage

Vivo Capital's whole portfolioVivo Capital's profile

Stage not reported

23

Series B

18

Series C and later

12

Series A

10

Pre-seed and seed

4

Segment by segment

Stage not reported

23 startups · $4.0B raised

  1. Candid TherapeuticsCandid Therapeutics was a clinical-stage biotechnology company based in San Diego, California, founded in 2024.United States$875M
  2. Legend BiotechLegend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.United States$576M
  3. Immunic TherapeuticsImmunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.United States$400M
  4. ValnevaValneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.France$310M
  5. Biohaven PharmaceuticalBiohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.United States$280M
  6. COMPASS PathwaysCompass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.United Kingdom$200M
  7. Tourmaline BioTourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.United States$173M
  8. CelladonCelladon is a biotechnology company developing molecular therapies for the treatment of heart failure.United States$172M

Series B

18 startups · $3.5B raised

  1. Terns PharmaceuticalsTerns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.United States$730M
  2. CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
  3. Passage BioPassage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.United States$380M
  4. Expedition TherapeuticsExpedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024.United States$280M
  5. SurrozenSurrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.United States$258M
  6. BBBolt BiotherapeuticsBolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.United States$189M
  7. Gracell BiotechnologiesGracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.China$185M
  8. Homology MedicinesHomology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.United States$144M

Series C and later

12 startups · $2.0B raised

  1. Trevi TherapeuticsTrevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.United States$386M
  2. Coherus BiosciencesCoherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.United States$299M
  3. Arcutis BiotherapeuticsArcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.United States$245M
  4. IGM BiosciencesIGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.United States$209M
  5. MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M
  6. RayzeBioRayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.United States$160M
  7. PulmocidePulmocide is a private biopharmaceutical company based in London, United Kingdom, founded in 2007.United Kingdom$110M
  8. INImpel NeuroPharmaUnited States$107M

Series A

10 startups · $1.7B raised

  1. CelcuityCelcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.United States$1.0B
  2. LBLepu BioChina$160M
  3. Clasp TherapeuticsClasp Therapeutics is a clinical-stage biotechnology company founded in 2020, focused on precision immuno-oncology.United States$150M
  4. IcosavaxIcosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.United States$119M
  5. Satsuma PharmaceuticalsSatsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.United States$92M
  6. Ablaze PharmaceuticalsAblaze Pharmaceuticals is a clinical-stage biopharmaceutical company based in Shanghai, China, with an office in San Diego, California.China$75M
  7. FTFortis TherapeuticsUnited States$58M
  8. Telum TherapeuticsTelum Therapeutics is a biotechnology and drug-discovery company based in Noáin, Navarra, Spain, founded in 2019.Spain$25M

Pre-seed and seed

4 startups · $26M raised

  1. Signadori BioSignadori Bio is the next-generation cellular immunotherapy for cancer cure.France$13M
  2. OneChain ImmunotherapeuticsOneChain Immunotherapeutics is a clinical-stage biotechnology company based in Barcelona, specializing in CAR-T and other immunothSpain$7.3M
  3. Integra TherapeuticsIntegra Therapeutics is a biotechnology company based in Barcelona, Spain, founded in 2020 as a spin-off from Pompeu Fabra University.Spain$3.2M
  4. Telomere TherapeuticsTelomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis-$2.3M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Vivo Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioVivo Capital's Pharma portfolio17 startups · $2.3BPortfolio mapVivo Capital portfolio map98 startups · $17BCo-investorsWho invests with Vivo Capital73 co-investorsSector portfolioRA Capital Management's Biotech portfolio197 startups · $38BSector portfolioOrbiMed's Biotech portfolio176 startups · $28BSector portfolioPioneer Fund's AI portfolio171 startups · $2.8B

Raising from investors like Vivo Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps